2015 -2019 Executive Director, Nonclinical and Clinical Pharmacology @
2008 -2015 Director, Drug Metabolism and Pharmacokinetics @
2007 -2008 Principal Investigator-DMPK @
2004 -2007 Senior Scientist II @
2001 -2004 Captain and Team Leader and Biochemist @
Todd Shearer Education
Medical University of South Carolina
PhD, Molecular and Cellular Biology
1997-2001
Medical University of South Carolina
M.S., Environmental Studies
1995-1997
Presbyterian College
B.S., Biology
1990-1994
Todd Shearer Skills
Pharmacokinetics
Drug Discovery
DMPK
Clinical Development
Pharmaceutical Industry
Drug Development
Metabolism
Biotechnology
HPLC
GLP
Small Molecules
Biopharmaceuticals
Drug Metabolism
Assay Development
Pharmacodynamics
Pharmacology
Toxicology
Biomarker Discovery
Chromatography
Lifesciences
CRO
Bioanalysis
IND
Ecotoxicology
Life Sciences
In Vitro
In Vivo
Laboratory
Biomarkers
ADME
Clinical Research
High Throughput Screening
LC-MS
Analytical Chemistry
Validation
FDA
Clinical Pharmacology
Clinical Trials
Biochemistry
Therapeutic Areas
Cell Culture
Business Development
Strategic Planning
Microsoft Excel
Lc Ms
Molecular Biology
High Throughput
Program Management
Business Strategy
Good Laboratory Practice Glp
Liquid Chromatography Mass Spectrometry Lc Ms
Management
High Performance Liquid Chromatography Hplc
High Performance Liquid Chromatography
Good Laboratory Practice
Liquid Chromatography Mass Spectrometry
Todd Shearer Summary
Todd Shearer, based in Chapel Hill, NC, US, is currently a Vice President at Cullinan Therapeutics. Todd Shearer brings experience from previous roles at Cullinan Therapeutics, SpringWorks Therapeutics and Nuventra Pharma Sciences. Todd Shearer holds a 1997 - 2001 PhD, Molecular and Cellular Biology @ Medical University of South Carolina. With a robust skill set that includes Pharmacokinetics, Drug Discovery, DMPK, Clinical Development, Pharmaceutical Industry and more. Todd Shearer has 3 emails and 12 mobile phone numbers on RocketReach.
Looking for a different Todd Shearer?
Find contact details for 700 million professionals.